{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T03:25:38Z","timestamp":1771817138008,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22007022"],"award-info":[{"award-number":["22007022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32360689"],"award-info":[{"award-number":["32360689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22364008"],"award-info":[{"award-number":["22364008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32260694"],"award-info":[{"award-number":["32260694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21867004"],"award-info":[{"award-number":["21867004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22007022"],"award-info":[{"award-number":["22007022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32360689"],"award-info":[{"award-number":["32360689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22364008"],"award-info":[{"award-number":["22364008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32260694"],"award-info":[{"award-number":["32260694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21867004"],"award-info":[{"award-number":["21867004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22007022, 32360689, 22364008, 32260694, 21867004"],"award-info":[{"award-number":["22007022, 32360689, 22364008, 32260694, 21867004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["ZZK[2021]034"],"award-info":[{"award-number":["ZZK[2021]034"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["ZK[2022]073"],"award-info":[{"award-number":["ZK[2022]073"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["ZZK[2021]034"],"award-info":[{"award-number":["ZZK[2021]034"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005329","name":"Natural Science Foundation of Guizhou Province","doi-asserted-by":"publisher","award":["ZK[2022]073"],"award-info":[{"award-number":["ZK[2022]073"]}],"id":[{"id":"10.13039\/501100005329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guizhou Provincial Young Science and Technology Talents Development Project","award":["KY[2022]146"],"award-info":[{"award-number":["KY[2022]146"]}]},{"name":"Top Science and Technology Talent Program of Guizhou Education Department","award":["2022075"],"award-info":[{"award-number":["2022075"]}]},{"name":"The Guizhou Provincial Foundation for Excellent Scholars Program","award":["GCC[2023]072"],"award-info":[{"award-number":["GCC[2023]072"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11030-024-11021-5","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T19:42:47Z","timestamp":1733773367000},"page":"4097-4115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synthesis, anticancer evaluation, preliminary mechanism study of novel 1, 2, 3-triazole-piperlongumine derivatives"],"prefix":"10.1007","volume":"29","author":[{"given":"Nianlin","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhurui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"11021_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"11021_CR2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1056\/NEJM199907153410306","volume":"341","author":"S Faderl","year":"1999","unstructured":"Faderl S, Talpaz M, Estrov Z, O\u2019Brien S, Kurzrock R, Kantarjian HM (1999) The biology of chronic myeloid leukemia. N Engl J Med 341:164\u2013172. https:\/\/doi.org\/10.1056\/NEJM199907153410306","journal-title":"N Engl J Med"},{"key":"11021_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/ajh.25792","volume":"95","author":"E Jabbour","year":"2020","unstructured":"Jabbour E, Kantarjian H (2020) Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol 95:691\u2013709. https:\/\/doi.org\/10.1002\/ajh.25792","journal-title":"Am J Hematol"},{"key":"11021_CR4","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1182\/blood.V90.9.3691","volume":"90","author":"MW Deininger","year":"1997","unstructured":"Deininger MW, Goldman JM, Melo JV (1997) The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells. Blood 90:3691\u20133698. https:\/\/doi.org\/10.1182\/blood.V90.9.3691","journal-title":"Blood"},{"key":"11021_CR5","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1128\/mcb.11.3.1553-1565.1991","volume":"11","author":"JR McWhirter","year":"1991","unstructured":"McWhirter JR, Wang JY (1991) Activation of tyrosine kinase and microfilament-binding functions of c-ABL by BCR sequences in BCR\/ABL fusion proteins. Mol Cell Biol 11:1553\u20131565. https:\/\/doi.org\/10.1128\/mcb.11.3.1553-1565.1991","journal-title":"Mol Cell Biol"},{"key":"11021_CR6","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1200\/JCO.2015.62.4718","volume":"33","author":"JJ Moslehi","year":"2015","unstructured":"Moslehi JJ, Deininger M (2015) Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia. J Clin Oncol 33:4210\u20134218. https:\/\/doi.org\/10.1200\/JCO.2015.62.4718","journal-title":"J Clin Oncol"},{"key":"11021_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3904\/kjm.2012.83.6.718","volume":"83","author":"DW Kim","year":"2012","unstructured":"Kim DW (2012) Recent advances of management for chronic myeloid leukemia. Korean J Med 83:718. https:\/\/doi.org\/10.3904\/kjm.2012.83.6.718","journal-title":"Korean J Med"},{"key":"11021_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.suponc.2011.08.001","volume":"10","author":"M Cornelison","year":"2012","unstructured":"Cornelison M, Jabbour EJ, Welch MA (2012) Managing side effects of tyrosine kinase inhibitor therapy to optimize adherence in patients with chronic myeloid leukemia: the role of the midlevel practitioner. J Support Oncol 10:14\u201324. https:\/\/doi.org\/10.1016\/j.suponc.2011.08.001","journal-title":"J Support Oncol"},{"key":"11021_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.leukres.2013.01.021","volume":"37","author":"M Breccia","year":"2013","unstructured":"Breccia M, Alimena G (2013) Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors. Leuk Res 37:713\u2013720. https:\/\/doi.org\/10.1016\/j.leukres.2013.01.021","journal-title":"Leuk Res"},{"key":"11021_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104772","volume":"156","author":"SK Tripathi","year":"2020","unstructured":"Tripathi SK, Biswal BK (2020) Piperlongumine, a potent anticancer phytotherapeutic: perspectives on contemporary status and future possibilities as an anticancer agent. Pharmacol Res 156:104772. https:\/\/doi.org\/10.1016\/j.phrs.2020.104772","journal-title":"Pharmacol Res"},{"key":"11021_CR11","doi-asserted-by":"publisher","first-page":"26357","DOI":"10.1038\/srep26357","volume":"6","author":"J Zheng","year":"2016","unstructured":"Zheng J, Son DJ, Gu SM, Woo JR, Ham YW, Lee HP, Kim WJ, Jung JK, Hong JT (2016) Piperlongumine inhibits lung tumor growth via inhibition of the nuclear factor kappa B signaling pathway. Sci Rep 6:26357. https:\/\/doi.org\/10.1038\/srep26357","journal-title":"Sci Rep"},{"key":"11021_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.818326","volume":"12","author":"J Shi","year":"2022","unstructured":"Shi J, Xia Y, Wang H, Yi Z, Zhang R, Zhang X (2022) Piperlongumine is an NLRP3 inhibitor with anti-inflammatory activity. Front Pharmacol 12:818326. https:\/\/doi.org\/10.3389\/fphar.2021.818326","journal-title":"Front Pharmacol"},{"key":"11021_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2478\/jvetres-2021-0061","volume":"65","author":"N Lu","year":"2021","unstructured":"Lu N, Yang Y, Li X, Li J, Cheng J, Lv Z, Du Y (2021) The protective action of piperlongumine against mycobacterial pulmonary tuberculosis in its mitigation of inflammation and macrophage infiltration in male BALB\/c mice. J Vet Res 65:431\u2013440. https:\/\/doi.org\/10.2478\/jvetres-2021-0061","journal-title":"J Vet Res"},{"key":"11021_CR14","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3892\/etm.2015.2275","volume":"9","author":"Q Kang","year":"2015","unstructured":"Kang Q, Yan S (2015) Piperlongumine reverses doxorubicin resistance through the PI3K\/Akt signaling pathway in K562\/A02 human leukemia cells. Exp Ther Med 9:1345\u20131350. https:\/\/doi.org\/10.3892\/etm.2015.2275","journal-title":"Exp Ther Med"},{"key":"11021_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.bbrc.2014.08.028","volume":"452","author":"SS Han","year":"2014","unstructured":"Han SS, Han S, Kamberos NL (2014) Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance. Biochem Biophys Res Commun 452:669\u2013675. https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.028","journal-title":"Biochem Biophys Res Commun"},{"key":"11021_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.fct.2018.01.048","volume":"111","author":"JS Seok","year":"2018","unstructured":"Seok JS, Jeong CH, Petriello MC, Seo HG, Yoo H, Hong K, Han SG (2018) Piperlongumine decreases cell proliferation and the expression of cell cycle-associated proteins by inhibiting Akt pathway in human lung cancer cells. Food Chem Toxicol 111:9\u201318. https:\/\/doi.org\/10.1016\/j.fct.2018.01.048","journal-title":"Food Chem Toxicol"},{"key":"11021_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bbrc.2013.06.073","volume":"437","author":"JM Liu","year":"2013","unstructured":"Liu JM, Pan F, Li L, Liu QR, Chen Y, Xiong XX, Cheng K, Yu SB, Shi Z, Yu ACH (2013) Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation. Biochem Biophys Res Commun 437:87\u201393. https:\/\/doi.org\/10.1016\/j.bbrc.2013.06.073","journal-title":"Biochem Biophys Res Commun"},{"key":"11021_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3892\/ol.2015.3305","volume":"10","author":"W Li","year":"2015","unstructured":"Li W, Wen C, Bai H, Wang X, Zhang X, Huang L, Yang X, Iwamoto A, Liu H (2015) JNK signaling pathway is involved in piperlongumine-mediated apoptosis in human colorectal cancer HCT116 cells. Oncol Lett 10:709\u2013715. https:\/\/doi.org\/10.3892\/ol.2015.3305","journal-title":"Oncol Lett"},{"key":"11021_CR19","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1016\/j.bmc.2018.06.013","volume":"26","author":"X Liu","year":"2018","unstructured":"Liu X, Wang Y, Zhang X, Gao Z, Zhang S, Shi P, Zhang X, Song L, Hendrickson H, Zhou D, Zheng G (2018) Senolytic activity of piperlongumine analogues: synthesis and biological evaluation. Bioorg Med Chem 26:3925\u20133938. https:\/\/doi.org\/10.1016\/j.bmc.2018.06.013","journal-title":"Bioorg Med Chem"},{"key":"11021_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.bmcl.2016.08.016","volume":"27","author":"X Xu","year":"2017","unstructured":"Xu X, Fang X, Wang J, Zhu H (2017) Identification of novel ROS inducer by merging the fragments of piperlongumine and dicoumarol. Bioorg Med Chem Lett 27:1325\u20131328. https:\/\/doi.org\/10.1016\/j.bmcl.2016.08.016","journal-title":"Bioorg Med Chem Lett"},{"key":"11021_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ejmech.2017.06.046","volume":"138","author":"Y Zou","year":"2017","unstructured":"Zou Y, Yan C, Zhang H, Xu J, Zhang D, Huang Z, Zhang Y (2017) Synthesis and evaluation of N-heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents. Eur J Med Chem 138:313\u2013319. https:\/\/doi.org\/10.1016\/j.ejmech.2017.06.046","journal-title":"Eur J Med Chem"},{"key":"11021_CR22","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.1021\/acs.jmedchem.6b00772","volume":"59","author":"Y Liao","year":"2016","unstructured":"Liao Y, Niu X, Chen B, Edwards H, Xu L, Xie C, Lin H, Polin L, Taub JW, Ge Y, Qin Z (2016) Synthesis and antileukemic activities of piperlongumine and HDAC inhibitor hybrids against acute myeloid leukemia cells. J Med Chem 59:7974\u20137990. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00772","journal-title":"J Med Chem"},{"key":"11021_CR23","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1021\/acs.molpharmaceut.2c00215","volume":"19","author":"P Li","year":"2022","unstructured":"Li P, Guo X, Liu T, Liu Q, Yang J, Liu G (2022) Evaluation of hepatoprotective effects of piperlongumine derivative PL 1\u20133-loaded albumin nanoparticles on lipopolysaccharide\/d-galactosamine-induced acute liver injury in mice. Mol Pharm 19:4576\u20134587. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00215","journal-title":"Mol Pharm"},{"key":"11021_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114888","volume":"244","author":"C Deng","year":"2022","unstructured":"Deng C, Yan H, Wang J, Liu K, Liu B, Shi Y (2022) 1, 2, 3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens. Eur J Med Chem 244:114888. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114888","journal-title":"Eur J Med Chem"},{"key":"11021_CR25","doi-asserted-by":"publisher","first-page":"2100158","DOI":"10.1002\/ardp.202100158","volume":"355","author":"MM Alam","year":"2022","unstructured":"Alam MM (2022) 1, 2, 3-Triazole hybrids as anticancer agents: a review. Arch Pharm 355:2100158. https:\/\/doi.org\/10.1002\/ardp.202100158","journal-title":"Arch Pharm"},{"key":"11021_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111700","volume":"183","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhao SJ, Liu Y (2019) 1, 2, 3-Triazole-containing hybrids as potential anticancer agents: current developments, action mechanisms, and structure-activity relationships. Eur J Med Chem 183:111700. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111700","journal-title":"Eur J Med Chem"},{"key":"11021_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116578","volume":"275","author":"Q Guan","year":"2024","unstructured":"Guan Q, Gao Z, Chen Y, Guo C, Chen Y, Sun H (2024) Structural modification strategies of triazoles in anticancer drug development. Eur J Med Chem 275:116578. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116578","journal-title":"Eur J Med Chem"},{"key":"11021_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00044-022-03001-x","volume":"32","author":"M Ashram","year":"2023","unstructured":"Ashram M, Habashneh AY, Bardaweel S, Taha MO (2023) A click synthesis, molecular docking, and biological evaluation of 1, 2, 3-triazoles\u2013benzoxazepine hybrid as potential anticancer agents. Med Chem Res 32:271\u2013287. https:\/\/doi.org\/10.1007\/s00044-022-03001-x","journal-title":"Med Chem Res"},{"key":"11021_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138025","volume":"1308","author":"E Irrou","year":"2024","unstructured":"Irrou E, Elmachkour YA, El Haddad S, Riadi Y, Oubella A, Auhmani A, Rehman MT, AlAjmi MF, Morjani H, Sebbar NK, Ait Itto MY, Taha ML (2024) Targeted synthesis via the structure-activity relationship: biological evaluation of new 1, 2, 3-triazoles monoterpene as antitumor agents. J Mol Struct 1308:138025. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138025","journal-title":"J Mol Struct"},{"key":"11021_CR30","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1002\/slct.202101035","volume":"6","author":"AS Nipate","year":"2021","unstructured":"Nipate AS, Jadhav CK, Chate AV, Deshmukh TR, Sarkate AP, Gill CH (2021) Synthesis and in vitro anticancer activities of new 1, 4-disubstituted-1, 2, 3-triazoles derivatives through a click approach. ChemistrySelect 6:5173\u20135179. https:\/\/doi.org\/10.1002\/slct.202101035","journal-title":"ChemistrySelect"},{"key":"11021_CR31","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.phymed.2016.03.011","volume":"23","author":"JW Lee","year":"2016","unstructured":"Lee JW, Park S, Kim SY, Um SH, Moon EY (2016) Curcumin hampers the antitumor effect of vinblastine via the inhibition of microtubule dynamics and mitochondrial membrane potential in HeLa cervical cancer cells. Phytomedicine 23:705\u2013713. https:\/\/doi.org\/10.1016\/j.phymed.2016.03.011","journal-title":"Phytomedicine"},{"key":"11021_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10555-019-09789-2","volume":"38","author":"VL Payen","year":"2019","unstructured":"Payen VL, Zampieri LX, Porporato PE, Sonveaux P (2019) Pro- and antitumor effects of mitochondrial reactive oxygen species. Cancer Metastasis Rev 38:189\u2013203. https:\/\/doi.org\/10.1007\/s10555-019-09789-2","journal-title":"Cancer Metastasis Rev"},{"key":"11021_CR33","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2174\/138945006778559210","volume":"7","author":"I Ringshausen","year":"2006","unstructured":"Ringshausen I, Peschel C, Decker T (2006) Cell cycle inhibition in malignant lymphoma: disease control by attacking the cellular proliferation machinery. Curr Drug Targets 7:1349\u20131359. https:\/\/doi.org\/10.2174\/138945006778559210","journal-title":"Curr Drug Targets"},{"key":"11021_CR34","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL (2020) ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med 19:1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454","journal-title":"Exp Ther Med"},{"key":"11021_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114738","volume":"243","author":"J Qin","year":"2022","unstructured":"Qin J, Li H, Wang X, Zhang Y, Duan Y, Yao Y, Yang H, Sun M (2022) Discovery of a novel piperlongumine analogue as a microtubule polymerization inhibitor with potent anti-angiogenic and anti-metastatic efficacy. Eur J Med Chem 243:114738. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114738","journal-title":"Eur J Med Chem"},{"key":"11021_CR36","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.cclet.2020.08.049","volume":"32","author":"H Ma","year":"2021","unstructured":"Ma H, Wu Y, Zhang W, Zhang H, Miao Z, Zhuang C (2021) Radiosensitization of human pancreatic cancer by piperlongumine analogues. Chin Chem Lett 32:1197\u20131201. https:\/\/doi.org\/10.1016\/j.cclet.2020.08.049","journal-title":"Chin Chem Lett"},{"key":"11021_CR37","doi-asserted-by":"publisher","first-page":"14685","DOI":"10.1038\/s41598-023-41283-2","volume":"13","author":"M Mortazavi","year":"2023","unstructured":"Mortazavi M, Eskandari M, Moosavi F, Damghani T, Khoshneviszadeh M, Pirhadi S, Saso L, Edraki N, Firuzi O (2023) Novel quinazoline-1, 2, 3-triazole hybrids with anticancer and MET kinase targeting properties. Sci Rep 13:14685. https:\/\/doi.org\/10.1038\/s41598-023-41283-2","journal-title":"Sci Rep"},{"key":"11021_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115883","volume":"262","author":"XJ Fu","year":"2023","unstructured":"Fu XJ, Huang J, Li N, Liu YH, Liu QG, Yuan S, Xu Y, Chen YF, Zhao YX, Song J, Zhang SY, Bai YR (2023) Design, synthesis, and biological evaluation of N-benzylaryl cinnamide derivatives as tubulin polymerization inhibitors capable of promoting YAP degradation with potent anti-gastric cancer activities. Eur J Med Chem 262:115883. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115883","journal-title":"Eur J Med Chem"},{"key":"11021_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1039\/D3QO01109G","volume":"11","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhu W, Huang J, Luo F, Chen X, Fang C, Chen S, Liu Y, Hu S, Zhang A (2023) A simple method for N-arylation of secondary amides\/amines through a NaH-initiated aryne generation strategy. Org Chem Front 11:12\u201320. https:\/\/doi.org\/10.1039\/D3QO01109G","journal-title":"Org Chem Front"},{"key":"11021_CR40","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.bmcl.2017.03.062","volume":"27","author":"F Xie","year":"2017","unstructured":"Xie F, Ni T, Zhao J, Pang L, Li R, Cai Z, Ding Z, Wang T, Yu S, Jin Y, Zhang D, Jiang Y (2017) Design, synthesis, and in vitro evaluation of novel antifungal triazoles. Bioorg Med Chem Lett 27:2171\u20132173. https:\/\/doi.org\/10.1016\/j.bmcl.2017.03.062","journal-title":"Bioorg Med Chem Lett"},{"key":"11021_CR41","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/ijms24021450","volume":"24","author":"Y Zou","year":"2023","unstructured":"Zou Y, Zhang G, Li C, Long H, Chen D, Li Z, Ouyang W, Zhang Y, Wang Z (2023) Discovery of tryptanthrin and its derivatives and their activities against NSCLC in vitro via both apoptosis and autophagy pathways. Int J Mol Sci 24:1450. https:\/\/doi.org\/10.3390\/ijms24021450","journal-title":"Int J Mol Sci"},{"key":"11021_CR42","doi-asserted-by":"publisher","first-page":"8686","DOI":"10.3390\/ijms24108686","volume":"24","author":"C Wang","year":"2023","unstructured":"Wang C, Zhu M, Long X, Wang Q, Wang Z, Ouyang G (2023) Design, synthesis, and antitumor activity of 1H-indazole-3-amine derivatives. Int J Mol Sci 24:8686. https:\/\/doi.org\/10.3390\/ijms24108686","journal-title":"Int J Mol Sci"},{"key":"11021_CR43","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1039\/D3FO00601H","volume":"14","author":"L Chen","year":"2023","unstructured":"Chen L, Lin Y, Yan X, Ni H, Chen F, He F (2023) 3D-QSAR studies on the structure\u2013bitterness analysis of citrus flavonoids. Food Funct 14:4921\u20134930. https:\/\/doi.org\/10.1039\/D3FO00601H","journal-title":"Food Funct"},{"key":"11021_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canlet.2016.02.058","volume":"375","author":"P Zou","year":"2016","unstructured":"Zou P, Xia Y, Ji J, Chen W, Zhang J, Chen X, Rajamanickam V, Chen G, Wang Z, Chen L, Wang Y, Yang S, Liang G (2016) Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer. Cancer Lett 375:114\u2013126. https:\/\/doi.org\/10.1016\/j.canlet.2016.02.058","journal-title":"Cancer Lett"},{"key":"11021_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.904258","volume":"12","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Zhang H, Zhu M, Pu Q, Li J, Hu X (2022) \u03b2-Hydroxyisovaleryl-shikonin exerts an antitumor effect on pancreatic cancer through the PI3K\/AKT signaling pathway. Front Oncol 12:904258. https:\/\/doi.org\/10.3389\/fonc.2022.904258","journal-title":"Front Oncol"},{"key":"11021_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbrc.2013.01.017","volume":"431","author":"M Jarvius","year":"2013","unstructured":"Jarvius M, Frykn\u00e4s M, D\u2019Arcy P, Sun C, Rickardson L, Gullbo J, Haglund C, Nygren P, Linder S, Larsson R (2013) Piperlongumine induces inhibition of the ubiquitin\u2013proteasome system in cancer cells. Biochem Biophys Res Commun 431:117\u2013123. https:\/\/doi.org\/10.1016\/j.bbrc.2013.01.017","journal-title":"Biochem Biophys Res Commun"},{"key":"11021_CR47","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1038\/s41467-021-24961-5","volume":"12","author":"N Kong","year":"2021","unstructured":"Kong N, Zhang H, Feng C, Liu C, Xiao Y, Zhang X, Mei L, Kim JS, Tao W, Ji X (2021) Arsenene-mediated multiple independently targeted reactive oxygen species burst for cancer therapy. Nat Commun 12:4777. https:\/\/doi.org\/10.1038\/s41467-021-24961-5","journal-title":"Nat Commun"},{"key":"11021_CR48","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.3390\/molecules26113243","volume":"26","author":"AL Sun","year":"2021","unstructured":"Sun AL, Mu WW, Li YM, Sun YL, Li PX, Liu RM, Yang J, Liu GY (2021) Piperlongumine analogs promote A549 cell apoptosis through enhancing ROS generation. Molecules 26:3243. https:\/\/doi.org\/10.3390\/molecules26113243","journal-title":"Molecules"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-11021-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:25:06Z","timestamp":1758720306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-11021-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["11021"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-11021-5","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}